Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you use bolus in patients s/p mastectomy and reconstruction if they had dermal involvement?
Answer from: Radiation Oncologist at Community Practice
Pathological dermis involvement is a risk factor of LR and I would use bolus for this situation.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
While we are increasingly omitting bolus, dermal involvement would concern me and I would use bolus.
Comments
Radiation Oncologist at University of Miami/Jackson Memorial Medical Center
Drs. @Sushil Beriwal and @Chirag S. Shah, would yo...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
I typically start with 1st 13 fractions and will m...
9600
9602
Sign in or Register to read more
11755
11772
Related Questions
Would you consider omitting adjuvant radiation in a very elderly patient with a small triple negative breast cancer?
What are your top takeaways in Medical Oncology from SABCS 2024?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
What is the current paradigm for breast cancer diagnosed with isolated metastases prior to initial treatment?
Would you feel comfortable doing high tangents with ultra-hypofractionation?
What hotspot and heterogeneity metrics do you utilize when delivering PMRT to a patient who has had breast reconstruction?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
Do you prefer to use the FAST or FAST-Forward regimen when treating stage I breast cancer with an ultra-hypofractionated approach?
Is there any contraindication for a patient receiving omalizumab for treatment of her lung aspergillosis to receive adjuvant breast radiotherapy?